Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 3/20 | 0.39 |
| ▸ | FNTA | P49354 | 8/20 | 0.34 |
| ▸ | FNTB | P49356 | 6/20 | 0.34 |
| ▸ | PGGT1B | P53609 | 5/20 | 0.34 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.32 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL156418 | 0.95 | BTN3A1 (0.34) | BTN3A1FNTAFNTBPGGT1BLPAR2 | |
| Ammonia Solution, Strong SCHEMBL29131478 | 0.93 | BTN3A1 (0.33) | BTN3A1FNTAFNTBPGGT1BLPAR2 | |
| Ammonia Solution, Strong SCHEMBL29131480 | 0.92 | BTN3A1 (0.33) | BTN3A1 | |
| Ammonia Solution, Strong SCHEMBL29131479 | 0.92 | BTN3A1 (0.33) | BTN3A1 | |
| Ammonia Solution, Strong SCHEMBL29111943 | 0.88 | BTN3A1 (0.38) | BTN3A1FNTAFNTBPGGT1BFDPS | |
| Isopentenylpyrophosphate SCHEMBL1272412 | 0.85 | BTN3A1 (0.64) | BTN3A1FNTAFNTBPGGT1B | |
| SCHEMBL5057643 | 0.84 | BTN3A1 (0.41) | BTN3A1FNTAFNTBPGGT1BTDP1 | |
| SCHEMBL570545 | 0.82 | BTN3A1 (0.43) | BTN3A1FNTAFNTBPGGT1BLPAR2 | |
| SCHEMBL18530667 | 0.82 | ALDH1A1 (0.31) | — | |
| SCHEMBL14941354 | 0.80 | BTN3A1 (0.44) | BTN3A1FNTAFNTBPGGT1BLPAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080070268-A1 | Differential expression profiling analysis of cell culture phenotypes and the uses thereof | WYETH (US) | 2008-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080070268-A1 | Differential expression profiling analysis of cell culture phenotypes and the uses thereof | ANKRD52, PPP4R3A, PPP6R3 | BTN3A1 3177/4885FNTA 2341/4885FNTB 2368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.